Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

CME Gr Q1 2024 Adj EPS $2.50 Beats $2.45 Estimate, Sales $1.50B Beat $1.48B Estimate

Author: Benzinga Newsdesk | April 24, 2024 07:02am
CME Gr (NASDAQ:CME) reported quarterly earnings of $2.50 per share which beat the analyst consensus estimate of $2.45 by 2.04 percent. The company reported quarterly sales of $1.50 billion which beat the analyst consensus estimate of $1.48 billion by 1.27 percent. This is a 4.05 percent increase over sales of $1.44 billion the same period last year.

Posted In: CME


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist